Are you invested in any of these stocks? - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Are you invested in any of these stocks?

Feb 27, 2009

If yes, you would not like to read further. Or probably you would! Well, in the previous article, we had taken a look at stocks that have performed robustly over the last decade. In this article, we shall look at those stocks that have been the top underperformers during the same time frame.

Underperformers over a period of ten years

Tata Motors: First on the list is the stock of Tata Motors, which is the only stock to have dropped in value as compared to its price a decade ago. As compared to the Sensex's gain of 171%, the stock of Tata Motors is down by nearly 17% over the last decade.

Source: CMIE Prowess
If we look at the adjacent chart, we can notice that the stock has performed very well over a period of ten years. However, the last two years have been difficult for the company. It has gone through a variety of rough patches, foremost being the not so good timed acquisition of Jaguar Land Rover. It may be noted that the company made this acquisition at a time when it was incurring a huge capex (for capacity expansion) as well. In addition to this, Tata Motors ran into land acquisition issues with the West Bengal government, which led to the shifting of the 'Nano' plant. This not only led to a delay in the launch of the car but also cost overruns.

The current slowdown in CV demand made matters worse for the company as it led to serious cash flow problems. With the demand for vehicles dropping rapidly, especially the commercial vehicle segment (nearly 70% of Tata Motor's revenues), concerns regarding the company's outlook are reflected in its share price movement in the last year.

Source: CMIE Prowess
Hindalco Industries: Second in line is Hindalco Industries, the flagship company of the Aditya Birla Group and the industry leader in the aluminium and copper segments. It provided a point to point return of 3% during the period under consideration. This can be very well explained by the fact that the company operates in a commodity business which is cyclical in nature. Moreover the company underwent a change in its business model in 2003 by incorporating the copper business which has lower margins. Furthermore, in 2007 it acquired Novelis to catapult itself into the league of world's top 5 aluminium producers, as an integrated producer with low cost alumina and aluminium facilities combined with high-end rolling capabilities and a global footprint in 12 countries outside India. However, this led the company to dilute its equity and even raise substantial amount of debt to fund the acquisition.

Source: CMIE Prowess
Hindustan Unilever: While Hindustan Unilever (HUL) has been the best performing stock in 2008, its performance for a decade has not been as good. HUL has underperformed the market over the last ten years with the stock gaining by only 35%.

The company has reported a muted compounded annual growth rate of 5% in topline and 8% in profits in the last decade. While the financial performance in the recent years has been robust, HUL witnessed a decline in sales between CY01 to CY04. This was mainly on account of the economic slowdown, which led to low consumption levels, thereby restricting growth. Also the company's operating margins declined from 19.6% in CY02 to 13% in CY08. The reason behind the same has been on account of increasing competition, which further led to higher spending on advertisements. Over the years, HUL has been losing its market share in several key categories, which is an indication of the competition in the marketplace.

Source: CMIE Prowess
Ranbaxy Laboratories: With its stock increasing by only 44%, Ranbaxy has been among the worst performers on the index over the last decade. The reasons for the same are manifold. The company did well during the early part of the decade as it generated substantial revenues and profits from the US generics market and considerably improved its standing in the domestic market. By then, it had already started establishing a global footprint and became aggressive in challenging patents of global pharmaceutical majors. It also managed to cross the US$ 1 bn revenue mark in 2004.

But the major turning point came in 2005 as severe pricing pressure in the US generics market eroded its profits considerably. Since then growing its revenues at a brisk pace has not proven to be easy which has compelled the company to focus more on the emerging markets which generate higher profits. Not only that, the promoters' stake sale to Daiichi Sankyo and the troubles with the US FDA have obviously not gone down well with the investing community. While the company's revenues grew at a CAGR of 16% in the last 8 years, performance at the net profit level has been very volatile. This probably explains why this stock has not done well on the bourses.

Source: CMIE Prowess
Tata Steel: Last in the list is India's largest steel company, Tata Steel recording a point to point return of 95%. This translates into a compounded annual growth 7% over the last decade. The company made a major acquisition of Corus in FY07 by leveraging its balance sheet during the bull run of the steel sector. However, little did the company know that after a couple of years, the world will face one of its worst economic crisis. This changed the outlook for Corus as the demand for steel in Europe has slumped creating serious cash flow problems for the company. Moreover, the demand in the domestic market also slowed down thus raising concerns over the company's ability to pay back the debt. This led the stock price of the company to witness a major fall.


Equitymaster requests your view! Post a comment on "Are you invested in any of these stocks?". Click here!

  

More Views on News

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...

Sundaram Bluechip Fund: Will Hold the Stable Horses (Outside View)

Sep 18, 2020

PersonalFn briefly outlines the newly launched NFO note HSBC Corporate Bond Fund.

Wait! Don't Chase Smallcaps Now (Profit Hunter)

Sep 18, 2020

Let the markets take a breather before you jump in.

How Much Money Do You Need to Be a Professional Trader? (Fast Profits Daily)

Sep 17, 2020

In this video I'll answer a question I get asked often: How much capital do I really need to trade the markets for a living? Let's find out...

A Contrarian View on Whether You Should Load Up on Small Caps podcast (Views On News)

Sep 17, 2020

Rahul Shah discusses whether the SEBI circular is the perfect time to start investing in good quality small caps

More Views on News

Most Popular

Safe Stocks

Here are some insights on why buying safe blue chip stocks is not the easiest task in investing.

How the 8-Year Cycle Can Help Identify Multibaggers (Fast Profits Daily)

Sep 11, 2020

This is how you can apply the greed and fear cycle in the market to pick stocks.

I Recommended this Stock over Page Industries because it's Relevant to Doubling Your Income (Profit Hunter)

Sep 7, 2020

Things are not often what they seem in the market and how you can take advantage of this.

The NASDAQ Whale Could Harm Your Portfolio (Fast Profits Daily)

Sep 7, 2020

The discovery of Softbank pushing up prices on the NASDAQ will cause volatility in the market. Stay alert!

This Could Be the Best September for Auto Stocks (Profit Hunter)

Sep 11, 2020

Here's why I think this month could be a great for auto stocks.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Sep 18, 2020 (Close)

MARKET STATS